Bharat Serums And Vaccines Limited, a active public limited company, was established on 11 November 1993 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74110MH1993PLC075088. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1,167.16 Cr and a paid-up capital of ₹7.31 M.
Formerly known as Aksipro Diagnostics P Limited, Aksipro Diagnostics P Ltd. It upholds a compliant status. Employing 1,786 professional, Its leadership includes Bharat Anand (Additional Director), Sheetal Arora (Additional Director), Arjun Juneja (Additional Director). Past directors included Shweta Jalan, Vijaya Sampath, Surendra Lunia. It holds ₹651.80 Cr open charges and ₹65.00 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 3Rd Floor, Liberty Tower, Plot No. K-10,, Behind Reliable Plaza, Kalwa Industrial Estate,, Thane, Maharashtra, 400708.
U74110MH1993PLC075088
075088
11 November 1993
₹1,167.16 Cr
₹7.31 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bharat Serums And Vaccines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Anand | Additional Director | 18 Feb 2025 | Current |
| Sheetal Arora | Additional Director | 23 Oct 2024 | Current |
| Arjun Juneja | Additional Director | 23 Oct 2024 | Current |
| Satish Kumar Sharma | Additional Director | 20 May 2025 | Current |
| Sanjiv Hari Navangul | Ceo | 07 Feb 2025 | Current |
| Rajeev Juneja | Additional Director | 23 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 03 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 18 Feb 2025 | Past |
| Pramod Abcsdd | Director | 23 Oct 2024 | Past |
| Pramod Abcsdd | Director | 22 Sep 2021 | Past |
| Pramod Abcsdd | Director | 22 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bharat Serums And Vaccines Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 16.98% increase. The company also saw a substantial improvement in profitability, with a 420.76% increase in profit. The company's net worth moved up by a moderate rise of 2.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Bharat Serums And Vaccines had a promoter holding of 99.72% and a public holding of 0.28%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,518,000,000.00
₹650,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 2024 | Citi Bank N.A. | ₹200.00 Cr | Open |
| 29 Jun 2024 | Others | ₹25.00 Cr | Open |
| 10 Mar 2024 | Others | ₹8.00 M | Open |
| 19 Dec 2022 | Citi Bank N.A. | ₹185.00 Cr | Open |
| 18 Nov 2022 | Citi Bank N.A. | ₹25.00 Cr | Open |
Explore comprehensive loan charge details -
Bharat Serums And Vaccines has a workforce of 1786 employees as of Mar 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bharat Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Serums And Vaccines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bharat Serums And Vaccines Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Satish Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 20 May 2025 & has been associated with this company since 7 months 28 days . was completed.
Progress on Bharat Serums And Vaccines Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Bharat Anand was appointed as a Additional Director was appointed as a Additional Director on 18 Feb 2025 & has been associated with this company since 10 months 27 days . was completed.
Anju Kumari Jha was appointed as a Additional Director was appointed as a Additional Director on 18 Feb 2025 & has been associated with this company since 10 months 27 days . was recorded as a recent event.
The activity Sanjiv Hari Navangul was appointed as a Ceo was appointed as a Ceo on 11 Feb 2025 & has been associated with this company since 11 months 4 days . was completed.
BSV saves money and the environment with solar power plant. Amp Energy India helps BSV achieve sustainability goals and reduce carbon footprint. Pharma industry can also go green and save money. Thanks BSV and Amp Energy India for making it happen. #SustainableGoals #GoGreen #SaveMoney #PharmaIndustry.
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family. .
Promoters of Bharat Serums and Vaccines (BSV) are reconsidering their plan to exit their 50-year old business for around Rs 3,500 crore. .
They are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers..
The CIN of Bharat Serums And Vaccines Limited is U74110MH1993PLC075088.
Bharat Serums And Vaccines Limited is headquartered at 3Rd Floor, Liberty Tower, Plot No. K-10,, Behind Reliable Plaza, Kalwa Industrial Estate,, Thane, Maharashtra, 400708.
Bharat Serums And Vaccines Limited was incorporated on 11 November 1993.
The current directors of Bharat Serums And Vaccines Limited are
The primary industry of Bharat Serums And Vaccines Limited is Manufacturing.
Bharat Serums And Vaccines Limited is unlisted.
The authorized capital of Bharat Serums And Vaccines Limited is ₹1,167.16 Cr, and the paid-up capital is ₹7.31 M.
The compliance status of Bharat Serums And Vaccines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX